Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy.

Details

Ressource 1Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: Final published version
Serval ID
serval:BIB_864F3EA6F2FD
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy.
Journal
Muscle & nerve
Author(s)
Novy J., Rosselet A., Spertini O., Lobrinus J.A., Pabst T., Kuntzer T.
ISSN
1097-4598 (Electronic)
ISSN-L
0148-639X
Publication state
Published
Issued date
02/2010
Peer-reviewed
Oui
Volume
41
Number
2
Pages
286-287
Language
english
Notes
Publication types: Case Reports ; Letter
Publication Status: ppublish
PDF: Letter to the editor
Keywords
Antineoplastic Agents, Alkylating/therapeutic use, Dose-Response Relationship, Drug, Humans, Male, Melphalan/therapeutic use, Middle Aged, Myopathies, Nemaline/drug therapy, Paraproteinemias/drug therapy, Treatment Outcome
Pubmed
Web of science
Create date
24/02/2010 10:54
Last modification date
20/08/2019 15:45
Usage data